Skip to main content

Table 2 Short- and long-term survival for resected pancreatic cancer patients receiving chemotherapy estimated by the Kaplan-Meier method

From: Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study

Survival The US Belgium The Netherlands Slovenia Norway
OS (95% CI)1 OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI)
Short-term survival
 6-month 94 (94–95) 95 (94–96) 97 (96–98) 95 (89–98) 96 (91–99)
 9-month 87 (86–87) 86 (84–88) 89 (87–91) 79 (70–85) 90 (83–94)
Long-term survival
 1-year 77 (76–78) 77 (74–79) 79 (77–82) 69 (60–77) 77 (67–83)
 2-year 47 (46–48) 46 (43–49) 44 (40–47) 39 (30–47) 46 (36–55)
 3-year 31 (30–32) 29 (26–32) 29 (25–32) 21 (14–29) 27 (18–36)
 5-year 19 (18–20) 17 (14–20) 20 (16–23) 10 (5–17) 21 (12–31)
  1. 1Results were calculated using the Kaplan-Meier method and are shown as survival proportions (95% confidence intervals) [%]
  2. OS overall survival, CI confidence interval